Interleukin 1 receptor antagonist is associated with changes in body composition during physiological GH substitution in patients with adult-onset growth hormone deficiency.
Ueland
Thor
T
Research Institute for Internal Medicine, Rikshospitalet, Oslo University Hospital, Norway. thor.ueland@medisin.uio.no
Jørgensen
Anders P
AP
Godang
Kristin
K
Fougner
Kristian J
KJ
Aukrust
Pål
P
Burman
Pia
P
Bollerslev
Jens
J
D000273:Adipose Tissue / Q000187:drug effects / Q000378:metabolism; D000328:Adult; D001823:Body Composition / Q000187:drug effects*; D004311:Double-Blind Method; D005260:Female; D019382:Human Growth Hormone / Q000627:therapeutic use*; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000378:metabolism; D053590:Interleukin 1 Receptor Antagonist Protein / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D010919:Placebos
D053590:Interleukin 1 Receptor Antagonist Protein; D010919:Placebos; D019382:Human Growth Hormone; D007334:Insulin-Like Growth Factor I